Nirsevimab effectiveness was greater than 70% in infants under 9 months.
Influenza B activity is fueling rises in the Midwest and Central regions.
The hospitalization ratio of human rhinovirus to RSV days was 51%.
The FDA expects to make a decision by early June.
Flu indicators are rising in some parts of the nation, especially the Midwest and South-Central regions.
Hospitalization rates were highest among children 0 to 2 months old.
The results highlight the importance of supporting older adults so that their decision whether to have surgery isn't based on financial factors, the authors say.
GSK has applied for expanded RSV vaccine use in adults ages 50 to 59 who have underlying health conditions.
In a preliminary flu season severity assessment, the CDC said the season has been moderate.
Most errors didn't result in an adverse event, and the few that did were recorded as nonserious.